XTL Biopharmaceuticals Ltd. (XTLB)

1.67
0.28 19.84
NASDAQ : Health Technology
Prev Close 1.40
Open 1.50
Day Low/High 1.50 / 1.83
52 Wk Low/High 1.37 / 3.85
Volume 3.46K
Avg Volume 1.40K
Exchange NASDAQ
Shares Outstanding 5.14M
Market Cap 7.99M
EPS 0.60
P/E Ratio 167.40
Div & Yield N.A. (N.A)

Ratings Changes Today

Upgrades: KORS, QADA, TTEK, WD Downgrades: AOSL, APC, BIG, CSH, DGSE, GSJK, QGEN, SYK, TDG, TTS, UAN, UWN, ZOLT, ZX Initiations: XTLB Read on to get TheStreet Quant Ratings' detailed report:

Ecolab Insider Sells $827.7 Million Worth

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Monday's Small-Cap Winners & Losers

Monday's Small-Cap Winners & Losers

InPlay Technologies climbs on a product order.

Wednesday's Small-Cap Winners & Losers

Wednesday's Small-Cap Winners & Losers

XTL Biopharma slips after suspending development of its hepatitis C treatment.

Tuesday's Small-Cap Winners & Losers

Tuesday's Small-Cap Winners & Losers

Smith & Wollensky surges.

Israeli Options Index Nears

Israeli Options Index Nears

The index would be the first to solely track Israeli companies.